ProGen PRP Advantage PROGEN-A30Recalls & reported problems
Bimini Technologies LLC · 30mL Platelet Rich Plasma production device. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00850034511573), received between Sep 24, 2022 and Nov 1, 2022 — classified as 3 injuries.
The most frequently reported specific device problem is “Off-Label Use” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Off-Label Use3
- Improper or Incorrect Procedure or Method1
Patient problems
- Hypersensitivity/Allergic reaction1
- Inflammation1
- Nodule1
- Subcutaneous Nodule1
- Swelling/ Edema1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryNov 1, 2022Off-Label Use; Off-Label Use
ENLARGED LYMPH NODES AND PRP INJECTION SITE ITCHING AND SWELLING WHERE PRP OBTAINED FROM THE DEVICE WAS USED TO SUPPORT HAIR GROWTH.
Patient problems: Swelling/ Edema
MAUDE report 15709451 ↗InjurySep 27, 2022Off-Label Use; Off-Label Use
NODULE DEVELOPMENT UNDER THE SKIN WHERE PRP OBTAINED FROM THE USE OF THE DEVICE WAS USED TO SUPPORT HAIR GROWTH.
Patient problems: Subcutaneous Nodule
MAUDE report 15495526 ↗InjurySep 24, 2022Off-Label Use; Improper or Incorrect Procedure or Method; Off-Label Use; Improper or Incorrect Procedure or Method
PRESUMED ASPIRATION AND SUBSEQUENT INJECTION OF SEPARATION GEL UNDER THE SKIN WHICH IS PRESUMED TO HAVE CAUSED AN ALLERGIC REACTION. ALL EVIDENCE SUPPORTS USER ERROR.
Patient problems: Hypersensitivity/Allergic reaction; Inflammation; Nodule
MAUDE report 15479447 ↗
Other Platelet And Plasma Separator For Bone Graft Handling devices
- Arthrex® ABS-10061TArthrex, Inc. · Platelet and plasma separator for bone graft handling75 reports
- Arthrex® ABS-10060RArthrex, Inc. · Platelet and plasma separator for bone graft handling66 reports
- Arthrex® ABS-10060Arthrex, Inc. · Platelet and plasma separator for bone graft handling59 reports
- Arthrex® ABS-10011Arthrex, Inc. · Platelet and plasma separator for bone graft handling51 reports
- Arthrex® ABS-10063Arthrex, Inc. · Platelet and plasma separator for bone graft handling49 reports
- Arthrex® ABS-10062TArthrex, Inc. · Platelet and plasma separator for bone graft handling35 reports
- Arthrex® ABS-10080Arthrex, Inc. · Platelet and plasma separator for bone graft handling9 reports
- Arthrex® ABS-2016-02Arthrex, Inc. · Platelet and plasma separator for bone graft handling7 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page